Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuropharmacology

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2012.01.010PMID 22300836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

  2013cited by this paper
• A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors

  2011cited by this paper
• Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

  2011influential reference
• Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

  2011influential reference
• etabotropic glutamate mGlu 2 receptor is necessary for the pharmacological nd behavioral effects induced by hallucinogenic 5-HT 2 A receptor agonists

  2011cited by this paper
• Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.

  2011cited by this paper
• Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo

  2010cited by this paper
• Functional crosstalk between GPCRs: with or without oligomerization.

  2010cited by this paper
• LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia.

  2010influential reference
• Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration

  2009cited by this paper
• Building a new conceptual framework for receptor heteromers.

  2009cited by this paper
• Activation of mGlu2/3 Metabotropic Glutamate Receptors Negatively Regulates the Stimulation of Inositol Phospholipid Hydrolysis Mediated by 5-Hydroxytryptamine2A Serotonin Receptors in the Frontal Cortex of Living Mice

  2009cited by this paper
• The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

  2008cited by this paper
• Identification of a serotonin/glutamate receptor complex implicated in psychosis

  2008influential reference
• Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

  2008cited by this paper
• Serotonin research: contributions to understanding psychoses.

  2008cited by this paper
• Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors*

  2008cited by this paper
• Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex.

  2008cited by this paper
• Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.

  2008cited by this paper
• A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis

  2007cited by this paper
• Activation of a Dimeric Metabotropic Glutamate Receptor by Intersubunit Rearrangement*

  2007cited by this paper
• Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

  2007influential reference
• International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Phenotype of schizophrenia: a review and formulation

  2005cited by this paper
• Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

  2003cited by this paper
• Schizophrenia: Neural Mechanisms for Novel Therapies

  2003cited by this paper
• The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.

  2002cited by this paper
• Principles and biophysical applications of lanthanide-based probes.

  2002cited by this paper
• [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.

  2001cited by this paper
• A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex.

  2001cited by this paper
• Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice.

  2000cited by this paper
• Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.

  2000influential reference
• Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors

  2000cited by this paper
• Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.

  1999cited by this paper
• Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action

  1998cited by this paper
• Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

  1998influential reference
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.

  1994cited by this paper
• The alpha 2-adrenoceptor antagonists idazoxan and yohimbine can unmask the postsynaptic dopamine agonist effects of B-HT 920.

  1989cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Antipsychotic drugs, neurotransmitters, and schizophrenia.

  1978cited by this paper
• Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.

  1972cited by this paper

• Allosteric activation of the glutamate receptor mGlu2 by the serotonin receptor 5-HT2A.

  2026cites this paper
• The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity

  2025cites this paper
• Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors.

  2025cites this paper
• Clozapine's Molecular Signature: Selective 5‐HT2A Receptor Downregulation and Signalling in Rat Brain Cortical Regions

  2025cites this paper
• Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?

  2024cites this paper
• Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders

  2023cites this paper
• The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia

  2023cites this paper
• Progress in metamodulation and receptor-receptor interaction: from physiology to pathology and therapy.

  2023cites this paper
• Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism

  2023cites this paper
• The crosstalk between 5-HT2AR and mGluR2 in schizophrenia.

  2023cites this paper
• Psychedelics: preclinical insights provide directions for future research

  2023cites this paper
• Metabotropic glutamate receptors in Parkinson's disease.

  2023cites this paper
• Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.

  2023cites this paper
• Preclinical models of treatment-resistant depression: challenges and perspectives

  2023cites this paper
• Low prepulse inhibition predicts lower social interaction, impaired spatial working memory, reference memory and cognitive flexibility in genetically heterogeneous rats.

  2023cites this paper
• Probing GPCR Dimerization Using Peptides

  2022cites this paper
• Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant

  2022cites this paper
• 5-HT 2A -mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: a 5-HT 2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis

  2022cites this paper
• Presynaptic 5-HT2A-mGlu2/3 Receptor–Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis

  2022cites this paper
• Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

  2022cites this paper
• Class A and C GPCR Dimers in Neurodegenerative Diseases

  2022cites this paper
• N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

  2022cites this paper
• Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice.

  2022cites this paper
• Identification of four residues within the TM4 of the 5-HT2A receptor necessary for 5-HT2A·mGlu2 heteromerization

  2021cites this paper
• Serotonergic metamodulation of mGlu2 3 receptors, a new mechanism for pain management: the case of trazodone

  2021cites this paper
• The evidence for and consequences of metabotropic glutamate receptor heterodimerization.

  2021cites this paper
• Cortical influences of serotonin and glutamate on layer V pyramidal neurons.

  2021cites this paper
• Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors

  2021influential citation
• Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease.

  2021cites this paper
• Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset

  2021cites this paper
• Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats

  2020cites this paper
• Acute Low Dose of Trazodone Recovers Glutamate Release Efficiency and mGlu2/3 Autoreceptor Impairments in the Spinal Cord of Rats Suffering From Chronic Sciatic Ligation

  2020cites this paper
• Interclass GPCR heteromerization affects localization and trafficking

  2020cites this paper
• Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays.

  2020cites this paper
• Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy and Treated with Gabapentin: A Randomized Controlled Pilot Study

  2020cites this paper
• Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset

  2020cites this paper
• Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.

  2020cites this paper
• Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex.

  2020cites this paper
• Understanding GPCR dimerization.

  2019cites this paper
• Serotonin and glutamate interactions in preclinical schizophrenia models.

  2019cites this paper
• Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism.

  2019cites this paper
• Oligomeric Receptor Complexes and Their Allosteric Receptor-Receptor Interactions in the Plasma Membrane Represent a New Biological Principle for Integration of Signals in the CNS

  2019cites this paper
• Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update

  2019influential citation
• P.562 Cross talk between spinal 5-HT2A and mGlu2/3 receptors and trazodone pain-related behaviours

  2019cites this paper
• The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines

  2018cites this paper
• Effect of Hallucinogens on Unconditioned Behavior.

  2018cites this paper
• Glutamate heteroreceptor complexes in the brain

  2018cites this paper
• 5-HT 2A Receptors and BDNF Regulation: Implications for Psychopathology

  2018cites this paper
• Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.

  2018influential citation
• Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen

  2018cites this paper
• 5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling

  2018cites this paper
• Hallucinogens in Drug Discrimination.

  2018cites this paper
• 5-HT 2A Receptor Heterodimerization

  2018cites this paper
• Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment

  2018cites this paper
• Brain Circuits Regulated by the 5-HT 2A Receptor: Behavioural Consequences on Anxiety and Fear Memory

  2018cites this paper
• Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

  2018cites this paper
• La phosphorylation du récepteur mGlu₂ du glutamate : mécanisme clé de son cross talk fonctionnel avec le récepteur 5-HT2A de la sérotonine

  2018cites this paper
• Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

  2018cites this paper
• 5‐HT2A‐mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5‐HT2A to mGlu2/3 signalling to amplify presynaptic mechanism of auto‐control of glutamate exocytosis

  2018influential citation
• Sedative effect of Clozapine is a function of 5-HT2A and environmental novelty.

  2017cites this paper
• Class A GPCR: Serotonin Receptors

  2017cites this paper
• Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

  2017cites this paper
• Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats

  2017cites this paper
• Contribution of heteromerization to G protein‐coupled receptor function

  2017cites this paper
• Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells

  2016cites this paper
• Neuropharmacology of N,N-dimethyltryptamine.

  2016influential citation
• Neurotransmitter receptor complexes: methods for bioanalysis, their potentials and limitations

  2016cites this paper
• Psychedelics

  2016cites this paper
• Current Techniques for Studying Oligomer Formations of G-Protein-Coupled Receptors Using Mammalian and Yeast Cells.

  2016cites this paper
• Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

  2016cites this paper
• Mechanism of Assembly and Cooperativity of Homomeric and Heteromeric Metabotropic Glutamate Receptors.

  2016cites this paper
• eview europharmacology of N , N-dimethyltryptamine heresa

  2016cites this paper
• Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System

  2016cites this paper
• Metabotropic Glutamate Receptors in Central Nervous System Diseases.

  2016cites this paper
• 5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

  2016cites this paper
• GGIP: Structure and sequence‐based GPCR–GPCR interaction pair predictor

  2016cites this paper
• Potential use of lurasidone for the treatment of bipolar psychosis

  2015cites this paper
• Allosteric Effects of G-Protein Coupled Receptor Heteromerization: Relevance to Psychosis

  2015cites this paper
• Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

  2015cites this paper
• Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?

  2015cites this paper
• ecent advances in the neuropsychopharmacology of serotonergic allucinogens

  2014cites this paper
• The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

  2014cites this paper
• Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.

  2014cites this paper
• N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.

  2014cites this paper
• Optical control and measurement of metabotropic glutamate receptors and K2P potassium channels

  2014cites this paper
• Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

  2014cites this paper
• Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment.

  2014cites this paper
• Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function mice.

  2013cites this paper
• The two faces of the pharmacological interaction of mGlu2 and 5-HT₂A - relevance of receptor heterocomplexes and interaction through functional brain pathways.

  2013influential citation
• Serotonergic hallucinogens as translational models relevant to schizophrenia.

  2013cites this paper
• From atomic structures to neuronal functions of g protein-coupled receptors.

  2013cites this paper
• The Prevalence, Maintenance, and Relevance of G Protein–Coupled Receptor Oligomerization

  2013cites this paper
• A fluorescent sensor for GABA and synthetic GABA(B) receptor ligands.

  2012cites this paper
• Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

  2012cites this paper
• A novel heterodimer of the GHS-R1a and the 5-HT2C receptor 1 Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signalling *

  2012cites this paper
• Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated Signaling*

  2012cites this paper
• BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues

  2012cites this paper
• Serotonergic mechanisms as targets for existing and novel antipsychotics.

  2012cites this paper
• Drug Design Strategies for GPCR Allosteric Modulators.

  2012cites this paper